The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma

OBJECTIVE: Sarcomas are a group of rare malignancies with various subtypes. Patients with metastatic sarcoma who have failed traditional treatments can possibly achieve better prognoses from using novel therapies, including anti-programmed death-1 (PD-1)-based therapies. METHODS: We retrospectively...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Jia, Li, Ting, Liao, Zhichao, Yu, Hui, Zhao, Yongtian, Wu, Haixiao, Ren, Zhiwu, Zhao, Jun, Xing, Ruwei, Teng, Sheng, Yang, Yun, Li, Xiangchun, Chen, Kexin, Trent, Jonathan, Yang, Jilong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Compuscript 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257312/
https://www.ncbi.nlm.nih.gov/pubmed/34817950
http://dx.doi.org/10.20892/j.issn.2095-3941.2021.0270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257312/
https://www.ncbi.nlm.nih.gov/pubmed/34817950
http://dx.doi.org/10.20892/j.issn.2095-3941.2021.0270

Ejemplares similares